These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 16954467

  • 1. NCI launches an innovative design for a breast cancer clinical trial.
    Whitworth A.
    J Natl Cancer Inst; 2006 Sep 06; 98(17):1178-9. PubMed ID: 16954467
    [No Abstract] [Full Text] [Related]

  • 2. Molecular assays to predict prognosis of breast cancer.
    Paik S.
    Clin Adv Hematol Oncol; 2007 Sep 06; 5(9):681-2. PubMed ID: 17982408
    [No Abstract] [Full Text] [Related]

  • 3. Review of breast cancer clinical trials conducted by the National Surgical Adjuvant Breast Project.
    Newman LA, Mamounas EP.
    Surg Clin North Am; 2007 Apr 06; 87(2):279-305, vii. PubMed ID: 17498527
    [Abstract] [Full Text] [Related]

  • 4. Clinical research. No lifeline for proposed breast cancer prevention trial.
    Kaiser J.
    Science; 2007 Jun 22; 316(5832):1679. PubMed ID: 17588904
    [No Abstract] [Full Text] [Related]

  • 5. NCI director opts against breast cancer prevention trial in favor of biomarkers.
    Savage L.
    J Natl Cancer Inst; 2007 Sep 05; 99(17):1282-3, 1289. PubMed ID: 17728206
    [No Abstract] [Full Text] [Related]

  • 6. NIH Consensus Development Conference summary: Adjuvant Chemotherapy of Breast Cancer.
    J Tenn Med Assoc; 1981 Mar 05; 74(3):190-2. PubMed ID: 7024644
    [No Abstract] [Full Text] [Related]

  • 7. Aromatase inhibitors for the treatment of breast cancer: is tamoxifen of historical interest only?
    Van Poznak CH, Hayes DF.
    J Natl Cancer Inst; 2006 Sep 20; 98(18):1261-3. PubMed ID: 16985239
    [No Abstract] [Full Text] [Related]

  • 8. Evaluating promising new treatments for life-threatening disease: implications of the HDC/ABMT experience for treating breast cancer.
    Edwards S.
    Find Brief; 2005 Jan 20; 8(1):1-3. PubMed ID: 15672527
    [No Abstract] [Full Text] [Related]

  • 9. Translational research in breast cancer.
    Chu QD, Holm N, Byrnes K, Li BD.
    Surg Oncol Clin N Am; 2008 Apr 20; 17(2):421-38, x. PubMed ID: 18375360
    [Abstract] [Full Text] [Related]

  • 10. High-dose chemotherapy for primary breast cancer: facts versus anecdotes.
    Hortobagyi GN.
    J Clin Oncol; 1999 Nov 20; 17(11 Suppl):25-9. PubMed ID: 10630258
    [No Abstract] [Full Text] [Related]

  • 11. Breast cancer gene microarrays pass muster.
    Twombly R.
    J Natl Cancer Inst; 2006 Oct 18; 98(20):1438-40. PubMed ID: 17047189
    [No Abstract] [Full Text] [Related]

  • 12. Biological therapy of breast cancer: recent clinical applications.
    Baar J.
    Curr Opin Investig Drugs; 2007 Dec 18; 8(12):987-95. PubMed ID: 18058569
    [Abstract] [Full Text] [Related]

  • 13. Adjuvant chemotherapy of breast cancer. Sponsored by the National Cancer Institute, assisted by the Office for Medical Applications of Research, NIH.
    Conn Med; 1980 Nov 18; 44(11):721-3. PubMed ID: 7226778
    [No Abstract] [Full Text] [Related]

  • 14. Clinical trials: a recent emphasis in the prevention program of the National Cancer Institute.
    DeWys WD, Greenwald P.
    Semin Oncol; 1983 Sep 18; 10(3):360-4. PubMed ID: 6665563
    [No Abstract] [Full Text] [Related]

  • 15. GATA-3 as a marker of hormone response in breast cancer.
    Fang SH, Chen Y, Weigel RJ.
    J Surg Res; 2009 Dec 18; 157(2):290-5. PubMed ID: 19059610
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Impact of randomized clinical trial results in the national comprehensive cancer network on the use of tamoxifen after breast surgery for ductal carcinoma in situ.
    Yen TW, Kuerer HM, Ottesen RA, Rouse L, Niland JC, Edge SB, Theriault RL, Weeks JC.
    J Clin Oncol; 2007 Aug 01; 25(22):3251-8. PubMed ID: 17577019
    [Abstract] [Full Text] [Related]

  • 18. Preoperative chemotherapy is safe in early breast cancer, even after 10 years of follow-up; clinical and translational results from the EORTC trial 10902.
    van Nes JG, Putter H, Julien JP, Tubiana-Hulin M, van de Vijver M, Bogaerts J, de Vos M, van de Velde CJ, Cooperating Investigators of the EORTC.
    Breast Cancer Res Treat; 2009 May 01; 115(1):101-13. PubMed ID: 18484198
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.